BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18449436)

  • 1. Incidence and features of heparin-induced thrombocytopenia (HIT) in burn patients: a retrospective study.
    Hejl CG; Leclerc T; Bargues L; Samson T; Foissaud V
    Thromb Haemost; 2008 May; 99(5):974-6. PubMed ID: 18449436
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.
    Schroder JN; Daneshmand MA; Villamizar NR; Petersen RP; Blue LJ; Welsby IJ; Lodge AJ; Ortel TL; Rogers JG; Milano CA
    Ann Thorac Surg; 2007 Sep; 84(3):841-5; discussion 845-6. PubMed ID: 17720387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke.
    Kawano H; Toyoda K; Miyata S; Yamamoto H; Okamoto A; Kakutani I; Walenga JM; Naritomi H; Minematsu K
    Cerebrovasc Dis; 2008; 26(6):641-9. PubMed ID: 18984950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
    Gettings EM; Brush KA; Van Cott EM; Hurford WE
    Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 10. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which patients undergoing cardiopulmonary bypass should be assessed for development of heparin-induced thrombocytopenia?
    Cummins D; Halil O; Amin S
    Thromb Haemost; 1995 May; 73(5):890. PubMed ID: 7482421
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support.
    Schenk S; El-Banayosy A; Prohaska W; Arusoglu L; Morshuis M; Koester-Eiserfunke W; Kizner L; Murray E; Eichler P; Koerfer R; Greinacher A
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1373-81.e4. PubMed ID: 16733172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia.
    Demasi R; Bode AP; Knupp C; Bogey W; Powell S
    Am Surg; 1994 Jan; 60(1):26-9. PubMed ID: 8273970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
    Demir M; Duran E; Yigitbasi O; Vural O; Kurum T; Yuksel M; Turgut B; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):279-84. PubMed ID: 17636189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis.
    Cuker A
    Thromb Haemost; 2011 Dec; 106(6):993-4. PubMed ID: 22012630
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of the 4Ts pretest clinical scoring system as a predictor of heparin-induced thrombocytopenia.
    Strutt JK; Mackey JE; Johnson SM; Sylvia LM
    Pharmacotherapy; 2011 Feb; 31(2):138-45. PubMed ID: 21275492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.